A medical therapeutic experiment is a multi-stage procedure aimed at applying an innovative method of treatment, technology or an innovative therapeutic preparation, which is not a standard therapy for a given illness. The medical therapeutic experiment is an alternative for patients who have not yet been treated or previous treatment has not produced the desired therapeutic effects. The main goal of the medical therapeutic experiment is to improve the patient’s health. The use of MSC therapy as part of a medical therapeutic experiment must always be supported by the consent of the Bioethical Commission at the District Medical Chamber in Częstochowa, Poland.
Wharton’s jelly-derived mesenchymal stem cells – WJ-MSC are a population of multipotent stem cells, located in the umbilical cord, classified as gelatinous connective tissue.
Wharton jelly is made up mainly of mucopolysaccharides, including hyaluronic acid and chondroitin sulphate.
The mesenchymal stem cells used in the experiment have a fibroblast structure, show adhesion to plastic substrates and originate from unrelated and incompatible in the antigen range of tissue compliance and the main groups and Rh blood factor, donor.
“The use of mesenchymal cells obtained from a Wharton jelly incompatible donor unrelated to the treatment of patients with type 1 diabetes”.
Who can take part in a medical therapeutic experiment in the field of diabetology?
Symptomatic type 1 diabetes, if not treated with injections, is a fatal disease. Comprehensively treated has a moderate impact on the expected life expectancy of a sick person.
General criteria for the selection of patients receiving therapy using WJ-MSC (Wharton’s jelly mesenchymal stem cells – Wharton jelly stem cells).
Exclusion criteria from therapy:
How can you qualify for MSC Therapy?
Patients are asked to send the following documents:
to the following address: firstname.lastname@example.org or by post: Centrum Medyczne Klara, MSC Therapy, ul. Wał Dwernickiego 43/45, 42-202 Częstochowa, Poland where initial verification will take place.
After doctor qualification for MSC Therapy, Klara Medical Center acts on behalf of the Patient for the Bioethical Commission at the District Medical Chamber in Częstochowa, Poland.
At this stage, patients wait for the application to be reviewed by the Bioethical Commission.
In the case of a positively examined application, Klara Medical Center contacts the patient in order to provide information on:
Diagram of a medical treatment experiment:
As part of the approval of the Bioethical Commission, the patient can receive up to 10 administrations of MSC. The duration of therapy is about 1.5 years.
Frequently Asked Questions:
The patient spends 3 days in the hospital.
Day 1 – admission to the ward
Day 2 – administration of the MSC preparation
Day 3 – hospital discharge in the morning hours
Yes, the cost in included.
If you would like to receive more information about stem cells treatment, please contact us at:
email@example.com and / or +48 34 534 5003